COMPARISON OF 3 DIFFERENT IMMUNOASSAYS FOR THE DETERMINATION OF CA 19-9 IN PANCREATIC CANCER PATIENTS - A NEW ASPECT OF POTENTIALLY CLINICAL RELEVANCE

被引：0
|
作者：
Klapdor, R. [1 ]
Bahlo, M. [1 ]
机构：
[1] ZeTDT GmbH, Internal Unit, Hamburg, Germany
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
328
引用
收藏
页码：5998 / 5999
页数：2
相关论文
共 50 条
  • [1] COMPARISON OF 3 DIFFERENT IMMUNOASSAYS FOR DETERMINATION OF CA 19-9 IN PANCREATIC CANCER PATIENTS - ANOTHER ASPECT OF POTENTIALLY CLINICAL RELEVANCE
    Klapdor, R.
    Bahlo, M.
    ANTICANCER RESEARCH, 2014, 34 (11) : 6828 - 6830
  • [2] Comparison of different Immunoassays for CA 19-9
    Stern, P
    Friedecky, B
    Bartos, V
    Bezdickova, D
    Vavrova, J
    Uhrova, J
    Rozprimova, L
    Zima, T
    Palicka, V
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (12) : 1278 - 1282
  • [3] Exploiting the relevance of CA 19-9 in pancreatic cancer
    Salleh, Syaza
    Thyagarajan, Anita
    Sahu, Ravi P.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
  • [4] Comparison of three immunoassays for CA 19-9
    Hotakainen, Kristina
    Tanner, Pirjo
    Alfthan, Henrik
    Haglund, Caj
    Stenman, Ulf-Hakan
    CLINICA CHIMICA ACTA, 2009, 400 (1-2) : 123 - 127
  • [5] Serum determination of CA 19-9 in diagnosing pancreatic cancer: An obituary
    Pezzilli, R.
    Casadei, R.
    Calculli, L.
    Santini, D.
    Morselli-Labate, A. M.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (01) : 73 - 74
  • [6] The impact of CA 19-9 on survival in patients with clinical stage I pancreatic cancer
    Melucci, Alexa D.
    Chacon, Alexander C.
    Burchard, Paul R.
    Ullman, Nicholas A.
    Tsagkalidis, Vasleios
    Casabianca, Anthony S.
    Reitz, Alexandra
    Swift, David A.
    Goyal, Subir
    Switchenko, Jeffrey M.
    Carpizo, Darren R.
    Shah, Mihir Maheshkumar
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [7] Impact of CA 19-9 on Survival in Patients with Clinical Stage I Pancreatic Cancer
    Melucci, Alexa D.
    Chacon, Alexander C.
    Burchard, Paul R.
    Ullman, Nicholas A.
    Tsagkalidis, Vasleios
    Casabianca, Anthony S.
    Reitz, Alexandra C.
    Swift, David A.
    Goyal, Subir
    Switchenko, Jeffrey
    Carpizo, Darren R.
    Shah, Mihir M.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 445 - 446
  • [8] CA 19-9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer
    Molina, Victor
    Visa, Laura
    Conill, Carles
    Navarro, Salvador
    Escudero, Jose M.
    Auge, Jose M.
    Filella, Xavier
    Lopez-Boado, Miguel A.
    Ferrer, Joana
    Fernandez-Cruz, Laureano
    Molina, Rafael
    TUMOR BIOLOGY, 2012, 33 (03) : 799 - 807
  • [9] CA 19-9: Not a magic marker for pancreatic cancer
    Daram, Sumanth R.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (03) : 205 - 205
  • [10] Is CA 19-9 useful in the management of pancreatic cancer?
    Balzano, Gianpaolo
    Di Carlo, Valerio
    LANCET ONCOLOGY, 2008, 9 (02): : 89 - 91
12345